Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 61 matching records
PLUVICTODepartment of Veterans Affairs$975.2K obligationsEnds Sep 30, 2024
PLUVICTO PROSTATE CANCER THERAPYDepartment of Veterans Affairs$2.1M obligationsEnds Sep 30, 2024
SIX BRANDED NUCLEAR MEDICINE FDA APPROVED LUTATHERA AND PLUVICTO.Department of Defense$498.4K obligationsEnds Dec 4, 2025
LUTATHERADepartment of Veterans Affairs$201.5K obligationsEnds Sep 30, 2024
GALLIUM DOTATATEDepartment of Veterans Affairs$22.4K obligationsEnds Nov 28, 2022
PLUVICTODepartment of Veterans Affairs$129.8K obligationsEnds Sep 30, 2024
PLUVICTODepartment of Veterans Affairs$129.8K obligationsEnds Sep 30, 2023
PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)Department of Veterans Affairs$0 obligationsEnds Nov 2, 2023
ADVANCED ACCELERATOR APPLICATIONS USA, INC.:1308250 [19-007105]Department of Health and Human Services$3.5K obligationsEnds Mar 14, 2020
LUTETIUM LUTATHERA & PLUVICTO FOR 1 YEARDepartment of Veterans Affairs$2.0M obligationsEnds Dec 31, 2023
NETSPOTDepartment of Veterans Affairs$224.6K obligationsEnds Sep 30, 2025